{"denomUnitsSelected":"Participants","description":"The association between onset of neurotoxicity and oxaliplatin exposure will be assessed. The difference in neurotoxicity rates between patients with and without a given polymorphism will be evaluated.","reportingStatus":"NOT_POSTED","timeFrame":"Assessed at baseline, every 2 weeks while on treatment, up to 10 years","title":"The Association Between Oxaliplatin Exposure, Allelic Variants in Candidate Genes, and Neurotoxicity","type":"OTHER_PRE_SPECIFIED"}